LOCALLY ADVANCED BREAST CANCER
Clinical trials for LOCALLY ADVANCED BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED BREAST CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to boost breast cancer remission before surgery
Disease control Not yet recruitingThis study tests a new drug combination (SHR-A1811 plus pertuzumab) given before surgery to women with early or locally advanced HR-positive, HER2-positive breast cancer. The goal is to see if this approach can eliminate cancer more effectively than standard chemo, while reducing…
Matched conditions: LOCALLY ADVANCED BREAST CANCER
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 26, 2026 03:12 UTC
-
New hope for breast cancer patients: extra drug may wipe out remaining tumor
Disease control Not yet recruitingThis study tests whether adding 4 cycles of the drug T-DXh can eliminate leftover cancer in women with HER2-positive breast cancer who still have disease after standard chemotherapy. About 59 participants will receive T-DXh before surgery. The goal is to see if more patients can …
Matched conditions: LOCALLY ADVANCED BREAST CANCER
Phase: PHASE4 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated May 26, 2026 03:09 UTC
-
Mind over tumor: therapy may boost chemo power in breast cancer
Symptom relief Not yet recruitingThis study tests whether a brief psychological therapy called Acceptance and Commitment Therapy (ACT) can improve how well chemotherapy works in women with locally advanced breast cancer. About 54 participants will either receive standard chemotherapy alone or with added ACT sess…
Matched conditions: LOCALLY ADVANCED BREAST CANCER
Phase: NA • Sponsor: Universitas Airlangga • Aim: Symptom relief
Last updated May 19, 2026 12:00 UTC